Biotech Stock ReportMay 23, 20193 minBioSig Allowed First Key US Patent Claims for its PURE EP™ System Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical s...
Biotech Stock ReportMay 8, 20193 minBioSig Technologies Completes Patient Cases at Indiana University Third Center to Use PURE EP(tm) System Santa Monica, CA, May 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company ...
Biotech Stock ReportMar 27, 20192 minBioSig Appoints John Kowalski to Lead Commercialization of PURE EPElectrophysiology Industry Veteran to Lead Sales Strategy for the Company’s Novel Cardiac Signal Acquisition and Processing Technology Santa Monica, CA, Feb....
Biotech Stock ReportMar 20, 20192 minMedical Leaders Join BioSig Clinical Advisory Board New Physician Board to Drive Adoption of PURE EP System Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a med...
Biotech Stock ReportFeb 20, 20192 minBioSig Announces Successful First-In-Human Use of PURE EP SystemEarly Results Suggest Improved Cardiac Signal Detection and Fidelity Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: B...
Biotech Stock ReportFeb 12, 20192 minBioSig Technologies Inc. Issues 2019 Shareholder LetterCompany provides updates on recent developments and highlights plans for future growth Santa Monica, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologie...
